19 June 2013
Keywords: herceptin, disappoints, lung, cancer, results, clinical, trial
Article | 03 June 2002
The results of a clinical trial of Roche/Genentech's anti-Her2 antibodyHerceptin (trastuzumab) in the treatment of patients with non-small cell
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 June 2002
18 June 2013
© 2013 thepharmaletter.com